TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
簡國龍Chien, Kuo-Liong
- 計畫主持人
- 執行臨床試驗年資 22 年 9 個月
-
klchien@ntu.edu.tw
發表文獻
111筆
51
WS Yang, PC Chen, HJ Lin, TC Su, HC Hsu, MF Chen, YT Lee, KL Chien: Type 2 Diabetes Mellitus as an Important Risk Factor for the Risk of Cancer Incidences: Report from a Prospective Community-based Cohort Study, Acta Diabetologica, 2017
52
TS Lai, MH Lee, HI Yang, SL You, SN Lu, LY Wang, Y Yuan, G L'Italien, KL Chien, CJ Chen for the REVEAL-HCV Study Group: High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease, Kidney International, 2017;92: 703–709.
53
TS Lai, MH Lee, HI Yang, SL You, SN Lu, LY Wang, Y Yuan, G L'Italien, KL Chien, CJ Chen, for the REVEAL-HCV Study Group: Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study., Hepatology, 2017; 66(3):784-793.
54
JL Luo, KL Chien, HC Hsu, TC Su, HJ Lin, PC Chen, MF Chen, YT Lee: Association between plasma homocysteine concentration and the risk of all-cause death in adults with diastolic dysfunction in a community, A 13-year cohort study, Medicine, 2017;96(17):e6716.
55
WC Tsai, HY Wu, YS Peng, JY Yang, HY Chen, YL Chiu, SP Hsu, MJ Ko, MF Pai, YK Tu, KY Hung, KL Chien: Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 2017;177(6):792-799
56
Tsai WC, Chien KL, Wu HY. Intensive Blood Pressure Control in Autosomal Dominant Polycystic Kidney Disease-How Safe Is It?-Reply. JAMA Internal Medicine. 2017;177:1695-1696.
57
Chien KL: Mini-Review of the Chin-Shan Community Cardiovascular Cohort study in Population Health Research in Taiwan, Acta Cardiologica Sinica, 2017; 33(3):226-232.
58
YH Li, KC Ueng, JS Jeng, MJ Charng, TH Lin, KL Chien, CY Wang, TH Chao, PY Liu, CH Su, SC Chien, CW Liou, SC Tang, CC Li, TY Yu, JW Chen, CC Wu, HI Yeh, for The Writing Group of 2017 Taiwan Lipid Guideline for High Risk Patients, 2017 Taiwan Lipid Guideline for High Risk Patients, Journal of the Formosan Medical Association, 2017; 116(4):217-248
59
Wu JHY, Marklund M, Imamura F, Tintle N, Ardisson Korat AV, de Goede J, Zhou X, Yang WS, de Oliveira Otto MC, Kroger J, Qureshi W, Virtanen JK, Bassett JK, Frazier-Wood AC, Lankinen M, Murphy RA, Rajaobelina K, Del Gobbo LC, Forouhi NG, Luben R, Khaw KT, Wareham N, Kalsbeek A, Veenstra J, Luo J, Hu FB, Lin HJ, Siscovick DS, Boeing H, Chen TA, Steffen B, Steffen LM, Hodge A, Eriksdottir G, Smith AV, Gudnason V, Harris TB, Brouwer IA, Berr C, Helmer C, Samieri C, Laakso M, Tsai MY, Giles GG, Nurmi T, Wagenknecht L, Schulze MB, Lemaitre RN, Chien KL, Soedamah-Muthu SS, Geleijnse JM, Sun Q, Harris WS, Lind L, Arnlov J, Riserus U, Micha R and Mozaffarian D. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. The Lancet Diabetes & Endocrinology. 2017;5:965-974.
60
Georgiadis P, Liampa I, Hebels DG, Krauskopf J, Chatziioannou A, Valavanis I, de Kok T, Kleinjans JCS, Bergdahl IA, Melin B, Spaeth F, Palli D, Vermeulen RCH, Vlaanderen J, Chadeau-Hyam M, Vineis P and Kyrtopoulos SA (co-authorship). Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis. BMC genomics. 2017;18:728.
